Clinical significance of p95HER2 Overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies


Tural D., Demirelli F., Serdengecti S., Ozturk T., Ilvan S. , Turna H., ...More

European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 27 September - 01 October 2013, vol.49 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 49
  • City: Amsterdam
  • Country: Netherlands